Killing the Golden Goose of US Drug Innovation: Drug Pricing Myths (Part II)

1 min

In September 2025, Brandon Phemester published Killing the Golden Goose of U.S. Drug Innovation: Drug Pricing Myths (Part II) in Life Sciences IP Review (LIPR). Click here to read.

Related Insights

New York City Proposes Strict Click-to-Cancel Subscription Requirements

April 27, 2026

5min

Federal Circuit Clarifies Written Description and Enablement Standards for Method-of-Treatment Patent Claims Using a Well-Known Antibody Genus

April 24, 2026

4min

HHS OIG Advisory Opinion: “No Remuneration” Ends the AKS Analysis

April 24, 2026

3min

Events

ABA Real Property, Trust and Estate Section Program

April 30, 2026

Expanding Your Nonprofit's Global Footprint: Practical Considerations and Key Developments

April 30, 2026

Independent Schools: School Year in Review and Key Legal Updates for 2026-2027

April 30, 2026

Recent News

Coverage of Paul Myers’ Arrival at Venable

April 22, 2026

1min

Megan Barbero Weighs in on Key SEC Disgorgement Issues in Law360 SCOTUS Coverage

April 22, 2026

1min

Michael Garfinkel Named Among Los Angeles Business Journal's Top 100 Lawyers in Los Angeles for 2026

April 21, 2026

1min

Subscribe Careers About News Offices